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                  DEMOGRAPHIC PROFILE AND EVALUATION OF  
          CEREBROVASCULAR ACCIDENTS IN PREGNANCY AND  
                                              PUERPERIUM 
1. INTRODUCTION 
Stroke in younger age groups is more common in females than males.The 
outcome is poor in females in terms of morbidity and mortality1. There have 
been many studies analyzing the role of female endocrine physiology in CVA. 
Pregnancy, hormonal contraceptives, and hormone replacement therapy are 
some of the female specific risk factors which have been analyzed by many 
authors2. Because of it s physiological prothrombotic state pregnancy and 
puerperium are known risk factors for Thrombo embolic disorders3. CVA 
during pregnancy and puerperium are recognized and feared complications as 
they account for around 12% of all maternal mortality. Since the direct causes 
for maternal mortality has been brought down, there is growing interest on the 
non-obstetric causes like stroke.4                  
Pregnancy related stroke has a wide spectrum of clinical presentation 
which makes it as a diagnostic and therapeutic challenge to the treating 
obstetrician. Development in the field of Neuroimaging helps us for early 
diagnosis and changed our approach towards this disorder. Here we discuss the 
relevant areas unique to pregnancy including the role of investigations, 
management and outcome. 
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AIM OF THE STUDY 
 
To study the demographic profile, predisposing factors, spectrum of 
clinical presentation, management and prognosis of Cerebro Vascular 
Accidents, which occur during pregnancy and puerperium. 
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REVIEW OF LITERATURE 
 
It has been estimated that more than 12% of maternal mortality occurs 
due to Cerebro Vascular Accidents. The morbidity in the survivors may be 
severe enough to cause permanent disability.4 During pregnancy and 
puerperium women have a hypercoagulable state which explains the higher 
incidence of CVA in this period.  According to the report published by Kittner 
et al, the average risk of being affected by haemorrhagic stroke during 
pregnancy is 2.5 times higher than non pregnant status and the risk further 
increases during puerperium. They also reported that the risk of ischemic stroke 
is 8-9 times greater in puerperium.5 The risk of CVA increases along with 
increasing maternal age particularly after 35 years.6  In a study by James et al, 
few medical conditions were found to have strong association with CVA when 
the affected woman becomes pregnant. They included migraine, inherited or 
acquired thrombophilias, connective tissue disorders, cardiac disease, sickle cell 
disease, hypertension, anemia and thrombocytopenia as risk factors.6 Conditions 
peculiar to pregnancy being significant risk factors were anaemia, postpartum 
haemorrhage, Hypertensive disorders of pregnancy, transfusion and postpartum 
infection.1 
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3.1.INCIDENCE 
Since CVA related to pregnancy and puerperium is not very common, it 
is difficult to arrive at an absolute risk above that of non pregnant group. In 
1995,Sharshar T et al from France reported that rate of CVA due to  
ischaemia/infarction was 11 per100 000 deliveries with the puerperal period 
carrying the maximum risk. They also reported that the risk of haemorrhagic 
stroke was 9 per100 000 deliveries, again with the maximum occurrence  in the 
puerperal period.7 Large population based studies are required to establish the 
incidence exactly, and reported incidence rates vary considerably.  
           The incidence of stroke in women of reproductive age group, who were 
not pregnant was reported to be 10.7/100000 women-years.8 Incidence of 
pregnancy-related stroke was calculated per 100 000 deliveries. It varied from 
4.3–210 cases per 100 000 deliveries.5,9 A recent population study in the USA 
analyzed the inpatient data from, 1000 hospitals. Through this study 2850 cases 
of CVA in pregnancy and puerperium were identified. This study reported the 
incidence of CVA related to pregnancy as 34.2 per 100 000 deliveries and 
women have 3 fold increased risk of CVA during pregnancy than non pregnant 
women.6 Wiebers and Whisnant reported 13-fold increased risk of stroke in 
pregnant females during the course of pregnancy and puerperium.10 
Previously it was thought that CVA in pregnancy and puerperium are 
secondary to thrombosis of cerebral veins only. A data analysis from Mexico 
showed that more than 50 percent of total cases of venous thrombosis were 
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pregnancy related.11 Though pregnancy shows increased risk for venous 
thrombosis, most of the cerebral infarctions are secondary to occlusion of 
arteries. Many studies have reported CVA due to ischaemia and haemorrhage in 
more or less similar proportions.12,13 But Jaigobin and Silver have reported the 
incidence of ischaemic stroke as 18 / 100 000 deliveries and haemorrhagic 
stroke as 8/ 100 000 deliveries.11 In India, prevalence of cerebral vein 
thrombosis is 4.5/ 1000 obstetric admissions. In our country CVT in the early 
puerperal period is 10 times higher than the Western countries.14 
Pregnancy associated CVA, particularly venous infarctions shows 
maximum incidence in the third trimester and the post partum period. Jaigobin 
and Silver analyzed 8 women with venous infarctions, 7 of which occurred in 
puerperal period.11 A study on pregnancy associated thrombo embolic disorders 
was conducted in Taiwan and showed that 73% of CVT occurred in the post 
partum period.15 A study from Sweden has shown that the risk of haemorrhagic 
and ischemic stroke is maximum during 2 days before and 1 day after delivery.8 
Data obtained through a population study from USA showed that around 90% 
CVA related to pregnancy occurred either during delivery or puerperium.1 
Lanska et al also have published a similar report.16 The mortality due to CVA in 
pregnancy and puerperium has been estimated to be 10-13%.6,17 
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3.2. ETIOLOGY 
3.2.1 PREDISPOSING CHANGES THAT OCCUR  IN  PREGNANCY 
 Hypercoagulability 
The following physiological changes take place during pregnancy 
leading to a hypercoagulable state 
• Raised level of  factor VIII 
• Raised level of von Willebrand factor 
•  Raised level of fibrinogen 
• Resistance to the action of  Protein C  
• Decreased level of  protein S 
•  Plasminogen activator inhibitors (PAI) 1 and 2 levels increased 
•  Hyperprolactinaemia mediated  platelet aggregation 
 Venous stasis 
 Stasis of blood in the venous system occurs due to the following factors. 
- Pelvic vessels are compressed by the enlarged uterus 
- Restricted mobility during pregnancy and puerperium 
 Endothelial injury 
• Vascular injury that occurs  during  parturition 
 Virchow has proposed a triad which includes Hypercoagulability, 
Venous stasis and Endothelial injury predisposing to venous 
thromboembolism18 
7 
 
 Extensive anatomical, physiological and biochemical changes take place 
throughout pregnancy which involves all important organs.  
 During pregnancy and puerperium coagulation and fibrinolytic systems 
are subjected to major changes and a lead to a prothrombotic state. It is a 
physiological preparation for delivery. These alterations are responsible 
for the pathogenesis of complications that occur during pregnancy and 
puerperium such as venous thromboembolism.1 
  Most of the procoagulant factors are at increased concentrations during 
conception especially von Willebrand factor, factor VIII and fibrinogen. 
Factor V level starts to increase after 16 week pregnancy.19 
 Apart from this, there is also progressive resistance to the action of 
Activated protein C, which is an anti coagulant 
  Protein S level starts decreasing around 10-11 wks and the decrease 
progresses throughout pregnancy. 19 
  Concentrations of PAI 1 and 2 are increased during pregnancy which 
interferes with Fibrinolysis.1 
 As a preparation for delivery and breast feeding, there will be a 
physiological increase in the concentration of prolactin during pregnancy 
this continues till puerperium. This physiological hyperprolactinaemia 
can cause platelet aggregation which is mediated through ADP 
stimulation.20 
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 Pregnancy related anatomical alterations like compression of great 
vessels by the enlarged uterus lead to venous stasis and increase the risk 
of thrombus formation. Doppler analysis of the venous system during 
pregnancy has shown progressive decrease in flow velocity. The flow 
velocity in the femoral vein at term is one third of that recorded during 
early months.21 
3.2.2 RISK FACTORS 
Risk factors that have been recognized to cause CVA in pregnancy and 
puerperium are the following6 
¾ High maternal age   
¾ Black race 
¾ Hypertensive disorders 
¾ Cardiac  disease 
¾  Smoking 
¾ Diabetes  Mellitus 
¾ SLE and other connective tissue disorders  
¾ Haemoglobinopathies  
¾ Vascular headache  
¾  Substance abuse especially cocaine 
¾ Caesarean section and  Instrumental  delivery 
¾ Fluid and electrolyte disorders especially dehydration  
¾ Inherited and acquired thrombophilias  
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¾ multiple pregnancy  
¾ multi parity  
¾ postpartum infections 
 
 The blood loss during parturition may lead to infection and dehydration 
and worsens the pro coagulant condition.1 
 Operative vaginal delivery and caesarean section increase the risk of 
CVA as surgically induced tissue damage causes reduction in protein C 
concentration which is an anti coagulant. Prolonged bed rest after 
operation reduces the blood flow in the lower limbs and contributes to 
venous stasis.1  
 Normal pregnancy itself is not associated with endothelial injury. But 
during the course of vaginal or abdominal delivery, some degree of 
damage to pelvic vessels may take place. This increases the risk of 
developing venous and arterial thromboembolism.1 
 Since atherosclerosis is not very common in younger age groups, other 
causes of CVA become increasingly important in these patients. 
Any of these risk factors may affect the pregnancy and puerperium 
usually in combination. We may face difficulties in establishing whether the 
stroke is due to pregnancy or incidental. 
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3.3. STROKE SYNDROMES OF PREGNANCY 
Here we will discuss the cerebro vascular events that are specific to 
pregnancy 
3.3.1. ECLAMPSIA AND POSTERIOR REVERSIBLE 
ENCEPHALOPATHY  SYNDROME 
 Studies have found that up to 5% of pregnancies are complicated by 
preeclampsia, otherwise known as Pre Eclamptic Toxemia (PET) and 1 in 
200 of these women develops eclampsia.3 
 PET is a hypertensive disorder peculiar to pregnancy and it complicates 
around 10% of all pregnancies.22,23Hypertension during pregnancy is 
defined as a sustained systolic BP of 140mmHg or more and/or diastolic 
BP of  90 mmHg or more which is evident on two occasions minimum 6 
hours apart but within 7 days.24 
 National Institute of Health Working Group has classified hypertension in 
pregnancy as24 
     1. Chronic hypertension 
          2. Gestational hypertension 
          3. Pre eclampsia and eclampsia 
          4. Pre eclampsia superimposed on eclampsia 
 Pre eclampsia and eclampsia accounts for 25%-45% of pregnancy-
associated Cerebro vascular accidents.1 The development of PET is 
characterized by hypertension, albuminuria and edema. There is 
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generalised endothelial dysfunction and vasospasm involving all major 
organs of body. 
 Pre eclampsia may also arise before 20 weeks of gestation. In case of 
thrombophilias, multiple pregnancy and molar pregnancy pre eclampsia 
may occur before 20 weeks. Sometimes it may arise in the postpartum 
period.1 
 Eclampsia is defined as the onset of seizures and/or unexplained coma 
during pregnancy or puerperium in a patient with features of pre 
eclampsia. Incidence of eclampsia in developing countries varies from 
1/100 deliveries to 1/1700. The seizures are usually generalized tonic 
clonic type.26 
  Eclampsia is more common in primigravida. The peak incidence is in the 
teenage years and early 20s. 
 Sharshar et al reported that both haemorrhagic and non-haemorrhagic 
stroke can occur in eclampsia.7 Studies have reported that patients with 
pre-eclampsia and eclampsia carry a greater risk for CVA. It has been 
observed that the most common cause of death in patients with eclampsia 
is intracerebral haemorrhage.27,28 
  The risk of ischaemic stroke related to Pre eclamptic toxaemia persists 
even after the postpartum period.29 Stroke Prevention in Young Women 
Study suggest that in those with a history of preeclampsia or eclampsia 
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during their pregnancy, the risk of  non-pregnancy-related ischaemic 
stroke in their later period of life  is 60% high.30 
 However it has been observed that hypertension alone cannot be 
responsible for the CVA, as intracerebral haemorrhage is relatively 
uncommon even with sustained elevated blood pressure. James et al have 
published a study stating that more than 75% of patients had diastolic 
pressure below 105mmHg before the event of stroke.6 
Pathophysiology 
 The exact pathophysiology of Pre Eclamptic Toxemia remains uncertain. 
But endothelial dysfunction and vasospasm appears to have an important 
role, suggesting relationship between PET and atherosclerosis.31 
 The basic pathology is an abnormal cytotrophoblast invasion in the spiral 
arterioles which is known as defective placentation. This leads to 
placental ischaemia. The placenta secretes vasoactive substances  and 
leads to endothelial dysfunction.31 
 In patients with pre eclampsia plasma rennin activity and angiotensin 
level are lower than normal. But there increased responsiveness to the 
pressor effect of angiotensin.32 
 Altered immunological response in the mother and oxidative stress also 
have a role in the pathogenesis of PET.24   
 Around 10% of patients present with Haemolysis, Elevated Liver 
enzymes and Low platelet count. The name HELLP syndrome was first 
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introduced by Louis Weinstein in 1982. It is associated with multi-organ 
failure resulting from endothelial damage, fibrin deposition and platelet 
aggregation. Isler CM et al from USA reported that in  HELLP syndrome 
the usual cause for maternal mortality is Cerebro Vascular Accidents.33 
  History of hypertension, heart disease or CVA in first degree relatives 
carries a higher risk for developing preeclampsia/eclampsia. It supports 
the rlole of  possible genetic risk factors.34 
  The cerebral autoregulation is maintained between a mean arterial 
pressure range of 60–150 mm Hg. Chronic hyperventilation in pregnancy 
may alter this mechanism. Many studies have reported that disturbance in 
the cerebral autoregulation leads to increased cerebral perfusion pressures 
which results in barotrauma and  damage to the vascular channels. 1 
 In patients with PET, increased vascular permeability causes third 
spacing of intravascular fluids. This leads to haemoconcentration and 
reduced intravascular volume. There is activation of the coagulation 
cascade with micro-thrombi formation. All these factors contribute to the 
overall picture of reduced tissue perfusion and greater risk for CVA. 
Clinical Features 
 Most of the patients present with classical features of preeclampsia like 
high blood pressure, subcutaneous edema and albuminuria. 
 In eclampsia, patients present with neurological features like headache, 
vomiting, convulsions and altered level of consciousness. Eclampsia 
14 
 
sometimes presents with sudden-onset focal neurological deficit 
consistent with CVA. 
 CT or MRI studies in patients with eclampsia revealed arterial ischaemic 
events or cerebral haemorrhage. 
 The prognosis is poor in cases with intracerebral haemorrhage. This may 
be because of that cerebral haemorrhage occurs usually in patients with 
severe pre-eclampsia, uncontrolled severe hypertension and intense 
endothelial dysfunction. Jeng JS et al reported that haemorrhagic lesions 
are more common in Asian women than Western women and this carries 
a higher mortality.15 
 In addition to ischemia and haemorrhage, reversible posterior 
encephalopathy syndrome [PRES] can also occur in pregnancy and rarely 
in puerperium as a consequence of uncontrolled preeclampsia. 
Autoregulatory mechanisms of posterior hemisphere are comparitively 
weaker than anterior. Patient develops vasogenic edema involving 
posterior part of cerebral hemisphere. Clinically patients present with 
headache, altered alertness or behaviour, convulsions and visual loss.  
 Untreated PRES may lead to severe cerebral ischaemia, infarction and 
even death.1 
 Important neurological problem that mimics eclampsia is cerebral venous 
thrombosis. But CVT usually prefers the puerperium. 
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Neuro Imaging 
 Computed Tomography shows normal study, especially when taken in the 
first day of the event. 
  MRI FLAIR sequences show Hyper intensity involving the occipital, 
parietal and lees frequently posterior frontal lobes. Cortex and subcortical 
parts of the above areas show  diffuse abnormal signal intensities. This is 
due to the white matter oedema occurring in the posterior part of cerebral 
hemisphere. 34 Bevan H et al reported that partial or asymmetric hyper 
intensities in MRI were more common with eclampsia comparing to other 
causes of PRES.35 
 Cytotoxic edema occurring due to ischaemic infarction may get confused 
with reversible vasogenic oedema.23 Diffusion-weighted MRI is useful to 
differentiate these two conditions.  
Management 
 The only definitive treatment for pre-eclampsia and eclampsia is 
termination of pregnancy. Pharmacological therapy focuses on the treatment of 
hypertension and prophylaxis against seizures. 
 Magnesium sulphate is the first-line therapy in both prophylactic and 
therapeutic management. It interferes with the action of post synaptic NMDA 
receptors of brain, inhibits the presynaptic GABA release and also reduces the 
intracytoplasmic calcium level by inhibiting calcium entry through voltage 
gated calcium channels.36 
  
 
 
 
MRI posterior reversible encephalopathy 
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 Patients with preeclampsia may have the chance of recurrence in the 
subsequent pregnancy. One recent publication has shown that patients with pre-
eclampsia have increased risk of  non-pregnancy related ischaemic stroke in 
future.29 Women with history of pre eclampsia or eclampsia should be aware of 
the risk factors for CVA and better to have regular follow up.   
3.3.2 POSTPARTUM CEREBRAL ANGIOPATHY (PCA) 
 PCA is characterized by reversible multifocal vasospasm involving the 
cerebral arteries.  
  Predisposing factors for PCA are pregnancy and puerperium, drug abuse, 
migraine, physical injury and hypercalcaemia. Sometimes it occurs without 
obvious precipitating factor.37,38,39 
 This problem may look similar to the syndrome that has been discussed with 
eclampsia. But antepartum and intrapartum periods are usually uneventful in 
these patients. PCA commonly manifests a few days after parturition.37,38 
  Common clinical features of PCA include acute onset of headache, 
photosensitivity, vomiting, altered sensorium, convulsions.  
 Studies have reported that cerebral vasoconstriction in PCA can cause a 
variety of neurological deficits. This is because of transient ischaemia, 
cerebral infarction and cerebral haemorrhage.40  
 Subarachnoid haemorrhage due to ruptured aneurysm, carotid or vertebral 
artery dissection, vasculitis of cerebral vessels, CVT, intracranial infection 
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and postpartum Sheehan syndrome are the important problems to be 
considered as differential diagnoses.1 
Pathophysiology 
The pathophysiology of PCA remains unclear. A disturbance in the 
control of vascular tone is likely to be the basic problem. This may look alike to 
the Posterior Reversible Encephalopathy Syndrome that has been described 
with eclampsia. Hence few authors mention that these both are same with 
variable presentation. But in contrast to eclampsia, the pathology of PCA is 
limited to the nervous system and patients have experienced pregnancy and 
delivery usually without any complications. Postpartum Cerebral Angiopathy 
has been reported with use of drugs causing vasoconstriction such as 
ergonovine and bromocriptine in the antepartum period.1,37 
Diagnosis 
Neuroimaging PCA shows segmental narrowing of the cerebral arteries at 
multiple sites. But complete recovery is noted in 1-2 months. 
   Cerebrospinal fluid analysis is useful in differentiating PCA from SAH as 
CSF analysis is normal in PCA. Brain biopsy may be required sometimes to 
differentiate PCA and vasculitis as both have different therapeutic implications. 
The obstetric significance regarding PCA is that it may get confused with CVT 
especially in postpartum stroke. Radiological investigations help in the 
diagnosis.1,40 
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Treatment 
Treatment of PCA is based on observational data obtained through 
clinical studies. Vasodilators and steroids have been proposed in the 
management of PCA but the disease process is usually a self-limiting with a 
benign course. Complete recovery from the symptoms and angiographic findings 
are observed in 1-2 months. Rarely intracerebral haemorrhage, death and 
recurrence in subsequent pregnancies may happen. 40,41 
3.3.3 ANEURYSM RUPTURE & SUB ARACHNOID HAEMORRHAGE 
The third common non obstetric cause for maternal mortality is 
haemorrhage due to aneurysm rupture. The most common cause for Sub 
Arachnoid Haemorrhage is rupture of intracerebral aneurysms. The classical 
symptoms are thunderclap headache, vomiting, convulsions and altered 
sensorium.42 When it occurs during pregnancy, it is difficult to differentiate 
from eclampsia. Radiological investigations and cerebrospinal fluid analysis are 
important to arrive at the diagnosis.  
The reported incidence of cerebral haemorrhage from aneurysmal rupture 
during pregnancy is around 5-10/100 000 pregnancies. In a woman with 
cerebral aneurysm the risk of haemorrhage during pregnancy and puerperium 
has been reported to be 5.6 times higher.5,7   
Aneurysms are most likely to rupture in the second half of pregnancy, 
and during the puerperal period. It has a greater mortality compared to general 
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population. Hormonal changes that occur during conception may increase the 
risk of aneurismal rupture.43 
Pathophysiology 
¾ Increased risk of aneurysmal rupture in pregnancy is attributable to the 
haemodynamic changes that occur during pregnancy. These changes are 
likely to cause aneurysm instability.1 
¾ It has been reported that during pregnancy there is hyperplasia involving 
the smooth muscles of arteries and disruption of elastic fibre alignment. 
Because of these changes the vessel wall becomes weak.1 
¾ Metabolic and hormonal factors related to pregnancy are also proposed as 
a reason for increased risk of SAH in pregnancy.  
¾ SAH without pre existing aneurysm may occur in eclampsia  
Management 
Surgical management after aneurismal SAH during pregnancy improves 
the outcome of both mother and fetus. Usually the management is similar to that 
of nonpregnant patients.1 Meyers PM et al have reported successful 
Endovascular techniques during pregnancy in the management of SAH. After 
successful treatment of the aneurysm, patient can continue the pregnancy till 
term.44 
Studies have shown that the route of delivery has no effect on the rate of 
maternal complications. Most clinicians prefer vaginal delivery. Caesarean 
section is done when the aneurysm is diagnosed at term, neurosurgical 
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intervention within one week before delivery, or other maternal or fetal 
indications for LSCS.  
3.3.4 CEREBRAL VENOUS THROMBOSIS  
CVT is any thrombosis occurring in intracerebral veins and sinuses and 
this is characterized by a wide range of clinical features depending on the sinus 
involved.  Women suffer with this disorder more common than men with a ratio 
of 3 to 1.45 Pregnancy and puerperium are the most significant procoagulant 
states leading to thrombosis in the cerebral venous system. Indian studies have 
reported that prevalence of CVT in Indian subcontinent is 4.5 per 1000 obstetric 
admissions.46 Panagariya et al from India has documented that CVT accounts 
for 50% of all young strokes and for 40% of strokes in females.47 
A. HISTORY OF CVT 
The puerperal CVT was first described in 1828 by John Abercrombie of 
Scotland.1 Since then the association between CVT and pregnancy has been 
explained by many authors.14 The risk of CVA due to venous thrombosis is 
higher during pregnancy than non-pregnant status. It was believed for a long 
time that almost all pregnancy related CVA were due to Cerebral Venous 
Thrombosis. But these studies were based on the observations made before the 
introduction of newer diagnostic procedures. In 1968, this concept was changed 
by Cross et al. He analyzed 31 patients with Cerebro Vascular Accidents that 
occurred during pregnancy and puerperium. He reported that most of the cases 
were due to arterial thrombosis and only one was due to venous occlusion.13 
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However, further studies have reported a greater incidence of venous infarcts in 
pregnancy associated stroke. Authors of those studies reported that the risk of 
pregnancy associated venous infarction is significantly greater during 
postpartum period.1 Srinivasan K from India published a report in 1984 
mentioning that CVT is responsible for around 20% of young stroke in India. 
He has observed around 50 cases of CVT per 10000 deliveries48. 
B. INCIDENCE 
During pre antibiotic era post infective CVT was more common where as 
pregnancy associated aseptic CVT has become popular after post antibiotic era.  
Lanska DJ et al analyzed data from the Healthcare Cost and Utilization Project 
and estimated a risk of 11.6 cases of pregnancy associated  CVT per 100 000 
deliveries.16  Jaigobin and Silver reported after analyzing 21 cases of cerebral 
infarction which occurred in pregnancy and puerperium over a 17-year period. 
Of these twenty one, 13 cases were arterial infarcts and eight cases were of 
venous origin. Of eight cases of venous origin seven cases reported in 
puerperium.11 
A recent study in Taiwan has reported 11 cases of pregnancy associated 
CVT, 73% of which were encountered in the postpartum period.15 Of 113 cases 
of CVT reported from Mexico City, 73 were related to pregnancy and  61 cases 
of these occurred in the puerperium.11 In India the incidence has been calculated 
to be  4.5/1000  obstetric admissions.46 
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C. ANATOMY OF CEREBRAL VENOUS SYSTEM 
Cerebral venous system can be classified into two major groups: 
1. Superficial system: It drains superficial surfaces of both cerebral 
hemispheres and it is formed by sagittal sinuses and cortical veins 
2. Deep system: It drains deep cortical veins of cerebral parenchyma and it 
is comprised by   lateral sinuses, straight sinus and sigmoid sinus. 
 Venous blood from the cerebral hemisphere flows through the superficial 
cortical veins and deep veins in to the venous sinuses of dura. There are 
numerous connections between the cortical veins and the dural venous 
sinuses .This anatomical setup facilitates the spread of the thrombus 
between these vessels. In the event of any occlusion it also permits 
formation of collaterals.  
 The venous sinuses are placed between the two rigid layers of duramater. 
These layers protect the sinuses from compression. 
  Central nervous system has no valves or muscular layer in the venous 
channels. Since the valves are absent blood can flow in either direction. 
The absence of muscular coat permits veins to remain dilated.52 
  The cortical veins of superior surface drain into the superior sagittal 
sinus against the blood stream of the same. It leads to turbulence in the 
blood stream. Fibrous septa which present at the inferior angle of the SSS 
further aggravate the turbulence. These factors are responsible for the 
high prevalence of Superior sagittal sinus thrombosis. 52 
23 
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D. ETIOPATHOGENESIS 
As stated earlier pregnancy associated hypercoagulability is the most 
important predisposing factor for CVT. After parturition, hypercoagulability 
worsens further due to volume depletion and trauma.  
The risk of peripartum CVT increases with  maternal hypertension, high 
maternal age, operative delivery, hyperemesis, dehydration and  infections.1 But 
Lanska et al has reported that more vulnerable age for peripartum CVT is 15-25 
year.49,50 In a report from India it has been observed that 112 cases out of 138 
were under 30 years of age. Increased risk of CVT during postpartum period is 
attributed to bad obstetric practices like delivery conducted by untrained 
persons and fluid restriction after delivery.47 Cantu et al has reported that cases 
of puerperal CVT show significantly higher incidence of anemia and raised 
ESR.11 
Obstetric CVT has an acute onset and better prognosis than thrombosis 
due to other causes.11 Peripartum CVT shows diversity of clinical features, 
mode of onset and neuroimaging signs due to which the diagnosis is often 
overlooked or delayed. The rate of death from peripartum CVT varies from 2% 
to10%. Studies have reported that mortality is significantly lower for peripartum 
CVT.11 When maternal deaths occur, they usually result secondary to 
intracerebral haemorrhage. Canhao P et al has observed that transtentorial 
herniation to be the most common cause of death.51 
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E. CAUSES OF CEREBRAL VENOUS THROMBOSIS 
a) Hypercoagulable Conditions. 
-Pregnancy and Puerperium 
-Hormonal Contraceptives 
-Anti-thrombin III deficiency 
-APLA Syndrome 
-Protein C & S abnormalities 
-Factor V Leiden and factor II gene mutations 
b) Changes in vessel wall. 
-Neoplasms 
-Infections : local or systemic 
 
 c) Changes in blood flow/viscosity. 
-Malnutrition 
-Dehydration 
-Cardiac failure 
-Hyperviscosity syndrome 
-Metabolic syndrome 
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F. PATHOLOGICAL CHANGES RELATED TO SYMPTOMS AND 
SIGNS: 
 Thrombus formation and obstruction of flow in the cortical veins can 
eventually lead to venous infarction. Due to infarction neurological 
symptoms and signs take place. 
 As a consequence of obstruction of flow in major venous sinuses, the 
venous pressure increases and there is impaired drainage of cerebrospinal 
fluid. This leads to increased intracranial tension casing severe headache 
and vomiting. Retinal examination shows papilloedema. 53 
 Obstruction of cerebral venous drainage leads to localized cerebral edema 
and venous infarction. The resulting ischemia causes neuronal damage 
and haemorrhagic spots. The distended veins sometimes lead to large 
haemorrhages.53 
 Local ischemia following venous occlusion causes release of cytotoxic 
substances. This eventually leads to damage of the energy dependant 
membrane pumps of cell wall and causes cellular edema.54 
 There is disruption of the blood brain barrier and leakage of plasma into 
the interstitial space. This leads to vasogenic edema.  If the venous 
occlusion is promptly managed it reverses gradually.1 
  Disruption of arachnoid villi located in the walls of major sinuses leads 
to poor drainage of CSF. This eventually results in increased intracranial 
tension.1  
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Because there is no pressure gradient, ventricular dilatation and 
hydrocephalus rarely occurs. 
 
G. CLINICAL FEATURES                    
Studies have found that peripartum CVT shows more acute course and 
early stabilization when compared to CVT in non pregnant population. Mental 
status changes are more common with peripartum CVT.11  
Clinical features depend on which vein is occluded and how fast the clot 
propagates in the vascular channel. 
 Headache: 
       It is the most common symptom in CVT. It may be due to stretching of 
nerve fibers in the walls of occluded veins, raised intra cranial pressure or 
local inflammation surrounding the clot. It can be of a thunderclap type 
mimicking subarachnoid haemorrhage.55 
 Focal Neurological Deficit:  
      Transient or long standing due to venous infarct 
 Encephalopathy  and  Convulsions 
 Rare clinical presentations: 
      Migraine with aura, pulsatile tinnitus, isolated psychiatric disturbances, 
isolated cranial nerve palsy, Sub arachnoid haemorrhage. 
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Neurological signs and symptoms in CVT and their frequency (%)56 
 
New onset headache 96% 
Focal neurological deficit 46% 
Paresis of one or more limbs 40% 
Convulsions ( generalized ) 37% 
Convulsions ( focal ) 10% 
Papilloedema 40% 
Altered consciousness - GCS<14 39% 
Coma – GCS<5 15% 
Isolated intracranial hypertension 20% 
Brainstem/ cerebellar signs 12% 
Dysphasia 22% 
Visual defects 10% 
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H. DIAGNOSIS OF CVT 
 Objectives of investigations are, 
- diagnosis of cerebral vein/sinus thrombosis 
-identification of vein/ sinus involved 
- identification of underlying pathogenic factors   
- evaluation of extent of neural damage 
1. NEURO IMAGING: 
Imaging studies play a key role in timely diagnosis of Cerebral Venous 
Thrombosis. 
A. Computed tomography: There are direct and indirect signs of CVT57,58 
Direct Signs of Cerebral Venous Thrombosis 
• The cord sign which is visible on CT scans without contrast 
enhancement represents the thrombosed cortical vein. Since it is a rare 
sign few studies question its diagnostic value.  
• The dense triangle sign: It is an early sign of SSS thrombosis. 
Spontaneous opaque  triangle area is visualized due to Superior Sagittal 
Sinus occlusion by freshly coagulated blood.  It presents in 2-3% of 
cases.  
• The empty delta sign/Empty triangle sign: It was described by 
Buonanno et al. It is evident in contrast CT images. It appears as a filling 
defect in the posterior part of SSS in case of occlusion. 
 
 
 
 
 
 
 
EMPTY DELTA SIGN 
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 It is the most common direct sign of CVT. In certain conditions the 
empty delta sign is not evident.  
(1) Thrombosis not involving the posterior part of the Superior Sagittal 
Sinus 
 (2)CT imaging performed either in the first 3 days or after 2 months of 
onset of symptoms.  
            False delta sign is noted in cases with early division of SSS. 
Indirect Signs in CT imaging: 
• Dense contrast enhancement of the falx and tentorium is evident in 20% 
of patients. It is due to venous stasis or congestion of the dural layer. 
• Visualization of small ventricles with swelling and diffuse hypodensity 
suggests cerebral edema. 
•  Hypodensity of white matter without contrast enhancement is indicative 
of cerebral edema. It is present in about 75% of patients. It may be diffuse 
or localized and is sometimes associated with mass effect. 
• Venous infarcts are haemorrhagic infarcts and they appear in CT scan as 
spontaneous hyperdense lesions in 10% to 50% cases. 
• In rare cases, there can be a subarachnoid hemorrhage or subdural 
hematoma along with other features. Sometimes it may be the only signs 
of CVT. 
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• Non - hemorrhagic venous infarcts appear as focal hypodense lesions 
with or without gyral enhancement. 
In 10% to 20% of clinically proven cases, CT imaging may be normal. It 
is more common with  patients presenting with isolated intracranial 
hypertension than  those with focal neurological features. CT may be normal 
where the venous infarct has not established completely. 58 
Only few patients show direct pathognomonic signs of CVT. But the 
indirect signs are evident in most of the patients. However, MRI or 
angiographic confirmation is suggested for appropriate management. 
B. Magnetic Resonance Imaging and Venography58,59 
The gold standard for the diagnosis of CVT is the combination of MRI 
which localizes the thrombus with  MRV which shows non visualization of the 
same. In day 1 to day5 the lesions appear as Isointense area in T1weighted MRI 
sequences and Hyperintense area in T2 weighted sequences. In day 5 -15, it 
becomes hyperintense in both sequences. Brain imaging can be normal 10-20% 
of patients. 
C. Trans cranial venous Doppler: 
It is useful in identification of tortuous, distended basal vein which occurs 
in Superior Sagittal Sinus thrombosis.  
2. D Dimer ASSAY: 
In most patients with recent CVT there is elevation of D Dimer 
concentration. A low value rules out the diagnosis. 
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3. LUMBAR PUNCTURE: 
It is not helpful in establishing the diagnosis of CVT. It may be used to 
rule out other causes like meningitis. 
4. MISCELLANEIOUS: Investigations to diagnose pro thrombotic conditions like 
APLA syndrome, Protein C or S deficiency, Factor V Leiden mutation, 
Homocysteinemia 
I.TREATMENT OF CEREBRAL VEIN THROMBOSIS 
Heparin anticoagulation is a time honoured treatment and it is used in all 
cases of CVT irrespective of the etiology.61,62,63  
Aims of anticoagulation are, 
-prevent extention of the thrombus 
- recanalise the occluded vein or sinus 
- treat the underlying prothrombotic state 
- prevent formation of thrombus in other parts of body 
- prevent recurrence 
Dose:  
The dose is variable and adjusted to maintain APTT at 1.5 to 2 times  
normal. Started as 5000 units iv bolus followed by infusion of 1000 units per 
hour. Subcutaneous route has unreliable bioavailability and delayed onset. 
Instead of Unfractionated heparin, Low molecular weight heparins like 
Enoxaparin, Dalteparin are used because of their reliable pharmacokinetics and 
poor side effects. Regular monitoring with coagulation profile is not required. 
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Heparin reduces both mortality and morbidity in CVT. Haemorrhagic infarct is 
not a contraindication for heparin therapy.63 Thrombolytic drugs like 
streptokinase and urokinase are also been tried in some patients and found to be 
effective. 
Symptomatic management: 
¾ Patient with raised ICT will improve with osmotic diuretics like 
mannitol, head up position, hyperventilation 
¾ Anti epileptic drugs to control seizures 
¾ Steroids have no role even in patients with parenchymal lesions 
¾ Physiotherapy 
¾ Hydration 
¾ Adequate care must be taken to prevent aspiration and bed sores. 
Long term management 
After the acute stage heparin is replaced by Warfarin for 6-12 months 
aiming an INR of 2-3. Patients with Thrombo embolic diseases like APLA 
syndrome are advised to have lifelong prophylaxis.64 
Recent guidelines from American College of Chest Physicians 
recommend that low-dose aspirin appears to be safe in the first trimester. 
Warfarin may be safe for the fetus after 12 weeks, it is not usually 
recommended during pregnancy because of uncertainty surrounding the risks. 
American Heart Association / American Stroke Association has suggested few 
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options for pregnant women with ischaemic stroke and high risk 
thromboembolic conditions:64 
¾ Dose adjusted high molecular weight heparin (UFH) throughout 
pregnancy with aPTT monitoring 
¾ Dose adjusted  low-molecular-weight heparin (LMWH) with factor Xa 
monitoring;  
UFH or LMWH until thirteen weeks of pregnancy followed by warfarin 
up to 34 weeks, after that Heparin injection till delivery.  
J. OUTCOME IN CVT: 
 Functional Recovery 
In patients with venous thrombosis, the chance for recovery of function is 
much better when compared to arterial thrombosis. Among all underlying 
conditions, the puerperal state is a favourable one with 80-90% survival. Cantu 
et al has mentioned that favourable outcome in puerperal CVT may be due to 
limited and transient occlusion with rapid recanalization or formation of 
collaterals. 
¾ Residual seizures has been reported in 10 - 30% of patients  who had 
seizures during the acute stage of CVT. 
¾ Recurrence of venous thrombosis at another site can occur in patients 
with prothrombotic states, but is generally uncommon with long term 
anticoagulation. 
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¾ One hundred of 138 cases of cerebral venous thrombosis related to 
pregnancy and the puerperium recovered completely in the series of 
Bansal et al.53 
¾ Srinivasan K in India observed 135 patients with CVT related to 
pregnancy (129 venous thrombosis and 6 arterial thrombosis).Among 
them 80 recovered without significant neurological deficit. Fifty of these 
cases followed up for 2 years were doing well. 10 patients had residual 
focal neurologic deficit without disability and 10 had recurrent seizures.46 
Mortality: 
The main causes of mortality in Cerebral Vein Thrombosis are, 
 Brain lesion itself, particularly large hemorrhagic infarcts 
 Associated complications like sepsis, uncontrolled seizures and 
pulmonary embolism. 
 Underlying conditions like carcinoma, septicemia, leukemia and 
Paroxysmal Nocturnal Haemoglobinuria. 
Factors suggestive of bad prognosis are as follows:1,76 
• Rate of evolution of thrombus 
• Age of the patient 
• Infection as a cause for CVT 
• Severe focal symptoms and coma 
• Presence of hemorrhagic infarct 
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• Empty delta sign on CT scan 
• Mass effect with midline shift 
 
K.  CRMD RECOMMENDATIONS: 
Confidential Review of Maternal Deaths, Kerala 2004-05 recommends 
the following in view of prevention of CVT75 
• Early ambulation 
• Early and adequate fluid intake 
• Use of elastic compression stockings 
• Change in the concept about BED REST 
Thromboprophylaxis if more than 3 of following risk factors exist 
(moderate risk) 
– Obesity (BMI > 30%) 
– Age > 35 
– Multiple pregnancy 
– Extensive varicose veins 
– Air travel 
– Cesarean or cesarean hysterectomy 
– Sickle cell anemia 
– Enforced bed rest > 4 days 
– APLA syndrome 
– Thrombophilia 
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Prophylactic heparin 
• LMWH 5000 units OR UFH 5000 units twice daily to be started 4 - 6 hrs after 
Vaginal delivery and 8 hrs after Cesarean section 
• Continue for 3 – 5 days or till the patient becomes fully ambulant 
 
3.3.5 PARADOXICAL EMBOLISM 
Around 25-30% of adults have Patent foramen ovale (PFO) which is an 
inter atrial communication. The association between cryptogenic stroke in the 
young and this inter atrial communication is well known as 50% of these 
patients have PFO.66 
Pathophysiology: 
The presence of communication between the two atria permits shunting 
of  emboli from right venous circulation into the left arterial circulation. This 
represents the most important pathophysiology behind the Paradoxical 
embolism.1 Clot formation due to stagnant blood flow may also occur within the 
atrial chambers. When there is susceptibility to atrial arrhythmias it further 
potentiates the risk of paradoxical embolism.66 
Many studies have described the association of PFO in pregnancy related 
CVA. As mentioned previously, pregnancy and puerperium are well known pro 
thrombotic states with an increased risk of venous thromboembolism. Hence 
venous thrombi, formed in the peripheral venous circulation, can reach the 
arterial circulation through the inter atrial communication. Straining during 
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second stage of labour may alter the pressure gradient across the atrial 
chambers, facilitating shunting of emboli from to left. The presence of PFO in a 
pregnant woman therefore provides an additional risk for CVA due to arterial 
occlusion. The CVA associated with PFO is an ischaemic stroke usually 
involving smaller areas. Patients with artificial cardiac valves may develop 
stroke due to cardio embolism. Rarely paradoxical amniotic emboli can cause 
venous or arterial events. Rare cases of air embolism resulting in ischaemic 
stroke during caesarean section have also been reported . 
Treatment: 
Treatment for patients having CVA due to paradoxical embolism includes 
drug therapy, in the form of warfarin or antiplatelet agents, and percutaneous 
transcatheter closure. ASA guidelines recommend use of aspirin for secondary 
prevention, while warfarin reserved for high-risk patients. Closure of atrial 
defect may be considered in patients with recurrent stroke in spite of adequate 
drug therapy. Transcatheter closure has been widely used nowadays67. 
Prophylactic anti thrombotic therapy is recommended for pregnant women with 
prosthetic valves and for those with history of stroke caused by paradoxical 
embolism.66  
3.3.6 PERIPARTUM CARDIOMYOPATHY (PPCM) 
Dilated cardiomyopathy is a well known risk factor for thrombo embolic 
stroke. PPCM is a disorder of unknown etiology which manifests in the 
peripartum period. It is characterized by symptoms of left ventricular failure in 
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women without pre-existing heart disease. Peripartum cardiomyopathy was first 
described in 1930s. A diagnostic criteria was established in 1971 which has 
been revised in 2000.68  
Peripartum cardiomyopathy is a diagnosis of exclusion. It is defined as 
cardiac failure that manifests anytime between last month of pregnancy and 5 
months postpartum in a woman without any underlying heart disease and 
without obvious cause for cardiac failure. Diagnostic criteria on 
echocardiography includes, 
 - Ejection fraction of less than 45% 
          - End diastolic shortening of less than 2.72cm/m2 
The incidence of PPCM has a wide geographical variation, ranging from 
1 in 2400 to 1 in 15000 pregnancies.1 The incidence is higher in Africans, 
elderly gravida, multiparous women and in whom pregnancy is complicated by 
multifetal gestation, hypertensive disorders or prolonged tocolytic therapy. 
Reported mortality associated with PPCM is about 18-50%1 
Pathophysiology 
The etiopathogenesis of peripartum cardiomyopathy is still unclear. 
Proposed causative factors are myocarditis, nutritional deficiency, altered 
immunology, stress induced cytokines and viral antigens. Stasis and thrombus 
formation in the dilated left ventricle  is common in PPCM which can cause 
peripheral embolisation. The triggered emboli results in tissue ischaemia and 
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infarction where it gets settled. When the emboli reach the cerebral circulation it 
leads to arterial infarction and stroke. 69 
Treatment 
Treatment of PPCM is similar to that of cardiac failure in non pregnant 
population. Drug therapy includes diuretics, digoxin and ACE inhibitors. 
Prophylactic antithrombotic therapy is advised to prevent thrombo embolic 
complications. Prognosis depends on normalization of left ventricular size and 
function within 6 months of delivery. However the risk of recurrence in 
subsequent pregnancies is 50-100%.1,69 
3.3.7 MISCELLANEOUS 
        Other etiological factors related to pregnancy associated stroke are, 
1. Arterial dissection, as a consequence of straining during second stage of 
labour; 
2. Disseminated intravascular coagulation due to obstetric complications 
causing intracerebral haemorrhage 
3.  Ovarian hyper stimulation syndrome causing Middle cerebral artery 
thrombosis70 
4.  stroke related to the use of anaesthetic drugs in pregnancy. 
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3.4. INVESTIGATIONS FOR STROKE IN PREGNANCY 
We should proceed with the investigations as in non pregnant state but 
with special considerations regarding pregnancy specific causes and teratogenic 
issues of the diagnostic procedures. Neuro imaging findings have been 
discussed already under concerned disorders.1 Here we shall discuss the issues 
regarding the adverse effects on the fetus. 
 Computed Tomography 
 CT Brain involves exposure to ionizing radiation. People have 
considerable anxiety in view of teratogenicity. The teratogenic effects of 
ionizing radiation on the fetus can lead to intra uterine death, congenital 
malformation, fetal growth restriction, damage to the central nervous system 
and cancer susceptibility. Risk is proportionate to the dose of radiation and 
duration of exposure. Absorbed dose is measured in rad or Gray. 
 The maximum estimated fetal absorbed dose of ionizing radiation is71 
- 50 mrad for a CT brain  
-10 mrad for cerebral angiography and  
- 1.0 mrad for a chest xray  
 However, natural background exposure existing at sea level is about 300 
mrad per year. When a fetus is exposed to radiation during maternal CT Brain 
study, the lifetime risk of developing cancer increases by 0.1%. Studies have 
reported that pregnant women exposed to < 5000 mrad have no additional risk 
to the fetus compared with women receiving background radiation alone.71,72 
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Magnetic Resonance imaging 
 MRI procedures do not cause ionizing radiation, and there are no 
documented adverse effects on the fetus. However any long-term effects are yet 
to be studied. Recent guidelines from the American College of Radiology 
suggest that pregnant patients can undergo MRI scans, provided that the 
potential risk/benefit ratio favours the procedure, unable to obtain the 
information through another non-ionizing technique, the information is required 
immediately and cannot wait until the patient completes her pregnancy.1 
 The contrast agents used in MRI studies can cross placental barrier easily. 
Guidelines suggest that administration of gadolinium-based MR contrast agents 
must be avoided unless potential benefit to the patient or fetus outweighs the 
theoretical risks. MRV has the advantages of being easily repeatable and 
noninvasive.72 
 Other investigations are Tests for haemotological abnormalities, Anti 
nuclear antibodies, Echocardiography, Tests for Lupus anticoagulant and Anti 
cardiolipin antibody, Coagulation profile, Lumbar puncture and D Dimer assay. 
 
3.5. MANAGEMENT OF CVA IN PREGNANCY AND PUERPERIUM 
 Specific treatment modalities related to individual causes of stroke have 
been discussed under the relevant sections. We shall discuss general issues 
regarding the role of thrombolytic therapy during pregnancy.  
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 The benefit of thrombolysis in acute venous and arterial occlusion is 
described by many authors. Historically use of thrombolytic agents during 
pregnancy is not being recommended because of concerns about fetal and 
maternal complications. Possible risks are preterm labour, abruption placenta, 
intra uterine death and PPH. There are no randomized controlled trials in 
pregnant patients available at present. Only clinical case series have been 
reported. 
 Murugappan et al reported 8 patients who had received thrombolytic 
therapy for acute ischaemic stroke during pregnancy. Seven patients had 
recovered well. 3 mothers had induced abortions, two spontaneous abortions, 
and 2 babies born healthy. 73 
 The benefits of thrombolytic therapy in reducing maternal mortality and 
morbidity should be outweighed against the potential risks.  
3.6 RECURRENCE: 
 Lamy et al has observed 489 patients with pregnancy related CVA. 13 
women had recurrence but only 2 of those encountered during pregnancy. He 
has mentioned that occurrence of stroke during pregnancy or puerperium is not 
a contraindication for subsequent pregnancies.7 
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MATERIALS AND METHODS 
 
 A study of the patients with cerebrovascular accidents during pregnancy 
and puerperium admitted in our Institution for a period of 22 months was done. 
Type of study: Prospective and Retrospective Analysis 
Population under study: 
 Patients admitted in Labour ward, Intensive medical care unit and 
Neurology unit of Tirunelveli Medical College Hospital with cerebrovascular 
accidents during pregnancy or puerperium from January 2011 to October 2012. 
Inclusion criteria: 
 Patients presenting with headache, altered sensorium, unifocal or 
multifocal seizures, neurological deficit and behavioral abnormalities during 
pregnancy or within six weeks of delivery. 
Exclusion criteria: 
                Patients with history of trauma, seizure disorder, infections 
(meningitis and encephalitis) and intracranial space occupying lesions. 
Data collection: 
 All patients admitted during the study period are subjected to analysis 
based on a proforma. 
¾ The details noted are age of the patient, socio economic status, parity, 
presence of predisposing   factors, time of presentation, mode of delivery 
and presenting symptoms. 
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¾ The general physical examination findings and vitals are recorded along 
with the findings on Neurological examination. 
¾ Laboratory and Radiological investigations are done according to 
available facilities in our institution. 
¾ Details about the treatment, course in hospital, outcome of treatment, and 
duration of hospital stay is done. 
 Detailed analysis of data is done at the end of the study period to find out 
the predisposing factors and the spectrum of presentation of CVA in pregnancy 
and puerperium. 
Main outcome measures: 
 The spectrum of cerebrovascular accidents in pregnancy and puerperium, 
its clinical presentation, management and outcome 
Secondary outcome measures: 
 The risk factors for CVA during pregnancy and puerperium and the 
prognosis based on them.  
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RESULTS AND ANALYSIS 
 
 87 patients with cerebrovascular accidents during pregnancy or 
puerperium admitted in Tirunelveli Medical College Hospital during a period of 
22 months were studied. 
The results of the study are documented below. 
 
AGE DISTRIBUTION OF CASES 
Table 1 
Total number of patients: 87 
AGE NO. OF PATIENTS PERCENTAGE 
< 18 YR 4 4.59% 
19 – 25 YR 48 55.17% 
26 – 30 YR 15 17.24% 
31 – 35 YR 15 17.24% 
>36 YR 5 5.74% 
 
 Maximum occurrence of CVA was noted in the age group of 19- 25 years 
contributing to 55.17 %. Similar incidence was noted in 26-30 yr and 31-35 yr 
age groups which was 17.24%. The youngest case of  stroke is a Primi of 17 
year old with Takayasu arteritis. 
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PARITY 
Table 2 
PARITY NO. OF PATIENTS PERCENTAGE 
G1 38 43.67% 
G2 24 27.58% 
G3 18 20.68% 
G4 and above 7 8.04% 
TOTAL 87  
 
G1- Antenatal patient with first conception (primi gravida) and postnatal patient 
after first delivery (primi para) irrespective of the outcome of the delivery.   
G2- Antenatal patient with second conception (G2A1,G2P1L0,G2P1L1) and 
postnatal patient after second delivery(A2, P2L0 ,P2L1 ,P2L2) irrespective of the 
outcome of previous and present pregnancies. 
G3- Antenatal patient with third conception and postnatal patient after third 
delivery, irrespective of the outcome of pregnancies. 
G4 – Patients with fourth conception or fourth delivery irrespective of the 
outcome of the delivery 
          43.67% of patients were primigravida or primi para (G1) which was the 
highest occurrence followed by G2 group showing 27.58% occurrence 
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SOCIOECONOMIC STATUS 
Table 3 
Socioeconomic class No. of patients Percentage 
Class I 2 2.29% 
Class II 7 8.04% 
Class III 17 19.54% 
Class IV 24 27.58% 
Class V 37 42.52% 
 
 Patients were classified using Modified Kuppusamy Scale. 42.52% of 
patients were from class V socio economic class followed by class IV with 
27.58%.   
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TIME OF PRESENTATION 
Table 5 
TIME OF  
PRESENTATION 
NO. OF PATIENTS 
 
PERCENTAGE 
ANTEPARTUM 17 19.54 
POSTPARTUM 70 80.45 
 
Table 6 
TIME OF  
PRESENTATION 
NO. OF PATIENTS 
 
PERCENTAGE 
I TRIMESTER 1 1.14% 
II TRIMESTER 4 4.59% 
III TRIMESTER 12 13.79% 
I WK 
POSTPARTUM 
20 22.98% 
II WK  
POSTPARTUM 
39 44.82% 
III WK 
POSTPARTUM 
7 8.04% 
IV WK 
POSTPARTUM 
4 4.59% 
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MODE OF DELIVERY 
Table 7 
Total number of patients: 70 
MODE OF DELIVERY NO OF 
PATIENTS 
PERCENTAGE 
LABOUR NATURALIS 24 34.28% 
INSTRUMENTAL 7 10% 
LSCS 39 55.71% 
                            
 Of all the patients with postpartum CVA 55.71% had undergone 
Caesarean section due to various reasons.  One patient had undergone Subtotal 
hysterectomy due to atonic PPH. 44.28% had undergone vaginal deliveries 
either Labour naturalis or Instrumental delivery 
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PREDISPOSING FACTORS 
Table 8 
RISK FACTOR 
NO OF 
PATIENTS 
PERCENTAGE 
HT  DISORDERS 39 44.82% 
ANAEMIA 54 62.06% 
LSCS 39 44.82% 
DEHYDRATION 24 27.58% 
BLOODTRANSFUSION 10 11.49% 
AGE > 35 5 5.74% 
GDM/DM 2 2.29% 
MULTIPLE PREGNANCY 4 4.59% 
AOTO IMMUNE DISORDER 2 2.29% 
HEART DISEASE 2 2.29% 
 
 Anaemia was present in 62.06% of patients and was the most common 
risk factor. Hypertensive disorders and caesarean section were present in 
44.82% patients. Three patients were chronic hypertensives. 11.49% of patients 
had undergone blood transfusion due to anemia, abruption or postpartum 
haemorrhage. One patient had undergone mitral valve replacement 2 year back 
and discontinued thrombo prophylaxis. 
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SYMPTOMATOLOGY 
Table 9 
TOTAL PATIENTS: 87 
SYMPTOM NO OF PATIENTS ERCENTAGE 
Headache 59 67.81% 
Convulsions 52 59.77% 
Altered sensorium 49 56.32% 
Visual disturbance 11 12.64% 
Neck stiffness 23 26.43% 
Fever 28 32.18% 
Vomiting 21 24.13% 
Neurological deficit 27 31.03% 
 
 In our study the most common symptom noted was Headache which was 
present in 67.81% of patients. Convulsions and Altered sensorium are the next 
two common symptoms with 59.77% and 56.32% respectively. 
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LEVEL OF CONSCIOUSNESS 
CONSCIOUS: 38       ALTERED SENSORIUM :  49 
Table 10 
LEVEL OF 
CONSCIOUSNESS 
NO. OF PATIENTS PERCENTAGE 
Conscious 38 43.67 
Drowsy 37 42.52 
Stuporous 8 9.19 
comatose 4 4.59 
 
 Of all the patients, 43.67% were conscious at the time of admission and 
during the hospital stay. Drowsiness was the most common feature of altered 
sensorium which was observed in 42.52% of patients. 
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SEIZURES 
TOTAL PATIENTS WITH SEIZURES: 52  
 
Table 11 
SEIZURES NO OF PATIENTS PERCENTAGE 
GTCS 41 78.84% 
FOCAL 11 21.15% 
 
 We observed that 59.77% of patients had convulsions at the time of 
admission or during the hospital stay. Most common type of seizures was GTCS 
with 78.84%. Focal seizures were present in 21.15% of patients.  
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BLOOD PRESSURE 
Table 12 
BP NO OF PATIENTS PERCENTAGE 
< 140 mmHg systolic 
and/ or  90 mmHg 
diastolic 
48 55.17 
>/= 140 systolic and/ or 
90 mmHg diastolic 
27 31.03 
>/= 160 systolic and/ or 
110mmHg diastolic 
12 13.79 
 
 In the present study 31.03% had blood pressure between 140/90 mmHg 
and 160/110 mmHg and 13.79% patients had blood pressure of more than 
160/110 mmHg.  Maximum patients had blood pressure below 140/90 mmHg 
with 55.17% 
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TEMPERATURE 
Table 13 
TEMPERATURE NO OF PATIENTS PERCENTAGE 
Febrile 28 32.18 
Afebrile 59 67.81 
 
 We observed that 32.18% of patients were febrile at the time of 
admission and 67.81% were afebrile. But we were not able to differentiate 
whether the fever had led to the occurrence of CVA or it was a result of CVA. 
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HAEMOGLOBIN LEVEL 
Table 14 
Hb % No. of patients Percentage 
Less than 4 g% 3 3.44 
4-7 g% 18 20.68 
7-10 g% 33 37.93 
More than 10g% 33 37.93 
 
 We observed that 62.06% of patients were anaemic with haemoglobin 
level less than 10g/dl of which 37.93% had severe anemia and 3.44% had very 
severe anemia. 
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FINDINGS ON NEURO IMAGING 
Table 15 
FINDINGS NO OF PATIENTS PERCENTAGE 
Haemorrhage 10 11.49 
Arterial infarct 8 9.19 
Venous infarct/ CVT 47 54.02 
PRES 14 16.09 
Normal 8 9.19 
 
Patients were subjected to CT scan (plain and contrast) and MRI with /without 
MR Venography.  
• Of 87 patients, 47 (54.02%) showed features of venous infarct/ CVT. 
Among them, 7 patients had normal CT findings and with the help of 
MRI they were diagnosed to have CVT.  
• 16.09% of patients had findings suggestive of PRES. 
• 8 patients with typical clinical features of CVT had normal findings in 
imaging studies. 
• 11.49% patients had Intra Cranial Haemorrhage which is a worse 
prognostic factor 
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SIGNS OF CVT IN NEURO IMAGING: 
Total patient with findings suggestive of CVT: 47 
Table 16 
FINDINGS NO OF PATIENTS PERCENTAGE 
Haemorrhagic infarct 21 44.68 
Edema 28 59.57 
Empty delta sign 13 27.65 
Non haemorrhagic infarct 15 31.91 
Cord sign 11 23.40 
Mass effect 11 23.40 
 
                 Total patients with clinical features of CVT were 55.Among them 8 
patient had normal CT finding. Of the 47 patients with findings of CVT, 
59.57% had cerebral edema. Considering the specific findings of CVT, most 
common feature was Haemorrhagic infarct with 44.68% followed by Non 
haemorrhagic infarct with 31.91%. Empty delta sign was present in 27.65% 
patients. Mass effect with midline shift was present in 23.40% of patients which 
indicates bad prognosis.  
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SINUSES INVOLVED IN CVT 
TOTAL PATIENTS: 47 
Table 17 
SINUS INVOLVED NO OF PATIENTS PERCENTAGE
Superior sagittal sinus 33 70.21 
Transverse sinus 16 34.04 
Sigmoid sinus 8 17.02 
Jugular sinus 4 8.51 
Straight sinus 4 8.51 
 
 Total patients diagnosed to have CVT were 55. Among them, 47 patients 
had features of CVT in CT/MRI/MRV. Of all the patients with findings of 
CVT, most common sinus involved was Superior Sagittal Sinus with 70.21% 
followed by the transverse sinus with 34.04% 
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OUT COME OF THE DISEASE 
Table 18 
Total patients: 87 
OUTCOME NO OF PATIENTS PERCENTAGE 
Recovered without 
residual problem 
60 68.96 
Recovered with 
residual problem 
15 17.24 
Death 12 13.79 
 
 We observed that 68 96% of patients showed good prognosis in the form 
of recovery without residual problem. Prognosis was good in patients who 
showed features of PRES and Venous infarct. We found that 17.24% of patients 
had recovered with residual deficit. The mortality was 13.79%. 
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MATERNAL MORTALITY 
Total Maternal Death in TVMCH in the study period (22 months): 87  
Maternal Death due to CVA: 12 [13.79%] 
 Patients with CVT showed less mortality compared to other problems like 
ICH and Arterial infarct. 
Of 12 patients, 50% had Hypertensive disorders either in the form of pre 
eclampsia or chronic hypertension 
Considering the  intra cranial pathology, 41.5% had Intra cranial haemorrhage. 
Of 12 patients, 5 patients had Cerebral Venous Thrombosis and all of them 
showed haemorrhagic infarct. 
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DISCUSSION 
 
 The occurrence of Cerebro Vascular Accident during peripartum period is 
a challenging, diagnostic and management problem. Since pregnancy and 
puerperium are pro coagulant states, women are at greater risk of Thrombo 
Embolic Diseases in this period.3 More than 50% young strokes in Indian 
women are related to pregnancy and puerperium14. Ischaemic strokes are more 
common than haemorrhagic strokes. Cerebral Venous Thrombosis leads as first 
cause for stroke in pregnancy and puerperium. Bansal et al in India reported 
puerperal CVT in a frequency of 4.5/ 1000 obstetric admissions.53 CVT has the 
maximum incidence in the puerperal period. 
 Whenever a risk factor like haematological abnormalities, immunological 
abnormalities, infections, dehydration ,pre eclampsia occur over the pre existing 
hyper coagulable state there is higher risk for Cerebro Vascular Accidents 
especially CVT. Unbooked status and home delivery have been proposed by 
many authors previously as important contributing factors. Nowadays these risk 
factors have been reduced due to implementation of our National health 
programmes. 
 The reported mortality due to CVT ranges from 5% to 30% which varies 
according to the time of detection and initiation of treatment.11 Neuro imaging 
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in the form of CT or MRI should be done at the earliest, after the onset of 
symptoms. 
 This study was carried out to evaluate the risk factors, spectrum of 
clinical presentation and outcome of Cerebral Vascular Accidents during 
pregnancy and puerperium. Due to unavailability  we were not able to do all the 
investigations. We had 87 patients who were diagnosed to have CVA in 
pregnancy and puerperium in a period of 22 months from January 2011 to 
October 2012. They were investigated to the maximum possibility, analyzed 
and the following observation was noted.  
AGE DISTRIBUTION: 
 Highest incidence of CVA occurred in the age group of 19-25 years. It 
contributes to 55.17% of total cases. This result is comparable to the results of 
the study conducted by Ameri et al., in 1992 with 61%.3,6 Lanska et al has 
published a report mentioning that 15-25 yr age group is more vulnerable to 
obstetric stroke.50 Age groups 26-30 yr and 31-35 yr had similar incidences 
17.24%. Youngest age of incidence was 17 years and the patient was a case of 
Takayasu arteritis. Incidence among> 36 yr age group may appear low but the 
mortality was high (40%), when compared to lower age groups.  
PARITY: 
 Among 87 patients, maximum incidence was noted in primi gravida and 
primi para which was 43.67%.  G2 group which includes second gravida and 
second para showed the incidence of 27.58%. The rate of grand multiparity has 
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been reduced now a days which explains low incidence of CVA in grand 
multipara. 
SOCIO ECONOMIC STATUS 
 Maximum occurrence of CVA was noticed in Class IV and V socio 
economic states, which was 70.10%.  This may be because most of the patients 
admitted to Tirunelveli Medical Collage Hospital belong to lower socio 
economic classes. Another explanation is that risk factors like anemia, poor 
nutrition, unbooked status and lack of awareness are more prevalent in lower 
socio economic classes. Prakash BC and Bansal C mentioned that reasons for 
higher incidence of CVA in lower socio economic groups need to be researched 
further.53 
AREA OF DISTRIBUTION 
 Among 87 patients with pregnancy related CVA 71.26% of patients are 
from rural area. This may be because of delayed identification of risk factors 
due to illiteracy and lack of awareness and poor accessibility to health care 
system. Wrong beliefs like post partum water restriction is prevalent in rural 
areas of Tirunelveli. 
TIME OF PRESENTATION 
 In our study 80% of CVA occurred in the post partum period. This is 
comparable to the results of study by Jeng JS et al., which is 73%.15 More than 
half of post partum CVA had occurred at II week of postpartum [44.82%].  
Prakash BC and Bansal C have reported that postpartum CVA usually occurs 7-
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10 days after delivery.53 Among 20% of antepartum strokes most of them had 
PRES and  higher occurrence was noticed during third trimester [13.79%].  One 
patient, who is a case of Systemic Lupus Erythematosus with renal failure, had 
stroke in first trimester. 
MODE OF DELIVERY 
 In the present study, 55.71% of patients with puerperal CVA had 
undergone caesarean section for various reasons. One patient had Subtotal 
Hysterectomy due to atonic PPH. Lanska DJ and Kryscio RJ mention that 
Caesarean section is an independent risk factor for obstetric CVT as it increases 
the risk by 3 times.16 Another explanation is that  most of these patients had 
Caesarean sections  for the indications like  pre eclampsia, diabetes and elderly 
primi which are proven risk factors for CVT. Instrumental delivery and 
caesarean section may increase the risk due to post surgical decline in protein C 
level because of surgically induced tissue damage.1 They also lead to prolonged 
immobilization which causes reduced blood flow to the legs resulting in venous 
stasis.  
PREDISPOSING FACTORS 
 CVA in pregnancy is usually a multi factorial disorder. When two or 
more risk factors co exists in a patient, the chance for CVA is high. In this study 
we found that Anemia [62.06%], Hypertensive disorders [44.82%], Caesarean 
delivery [44.82%], Dehydration [27.58%] and Transfusion [11.49%]  are the 
important predisposing factors for CVA. Sharshar T et al., has mentioned that 
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pre eclampsia and eclampsia are responsible for 25% to 45% of pregnancy 
related CVA. Brown et al  found that women with preeclampsia were 60% more 
likely to have ischemic stroke than women without it.30 
 Independent risk factors for CVT are the peripartum period, caesarean 
delivery, increasing maternal age, hyper emesis, infections, transfusions and 
maternal hypertension16. In Tirunelveli, people have a custom of severe water 
restriction in the postpartum period due to some wrong beliefs. It increases the 
risk of CVT when patients have other co morbid conditions like anemia, pre 
eclampsia, immunological abnormalities and fever.  
CLINICAL FEATURES 
1. HEADACHE: 
 We observed that headache was the most common symptom which 
usually precedes the neurological event.  In our study 67.81% of our patients 
presented with headache at the time of admission which is comparable to the 
study by Kumar S et al with 66% and Nagaraj et al with 71%.63 Convulsions 
and Altered sensorium are the next two common symptoms with 59.77% and 
56.32% respectively. The inference is that patients with severe, persistent 
headache during peripartum period should not be left unevaluated even in the 
absence of other neurological features.    
2. LEVEL OF CONSCIOUSNESS: 
 In our study we observed that 43.67% were conscious at the time of 
admission and during the disease course. 56.32% of patients presented with 
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altered sensorium. Of  those patients with altered level of consciousness 42.5% 
of patients were drowsy, 9% were stuporous and 4.5% were comatose. This 
result is comparable with Nagaraj et al from Tamilnadu who has reported 
altered sensorium in obstetric stroke as 57.53%. Neki S et al has reported 56% 
of altered sensorium in pregnancy related CVA.    
3. SEIZURES: 
 Fifty percent of patients with CVT have either focal or generalized 
seizures. They may be localized at the onset but may later become generalized. 
Rarely may they persist after an acute phase is over. Their early appearance is 
the hallmark of bad prognosis. In the present study 60% of patients presented 
with convulsions either at the time of admission or during hospital stay. It is 
similar to the report by  Kumar S et al  who has observed  66% in 85 patients. 
Of 52 patients with seizures in our study, 78.84% was Generalized Tonic Clonic 
Seizures and 21.15% was Focal seizures.  
4. NEUROLOGICAL SIGNS: 
 In the present study 31.03% of patients had neurological deficits like 
hemiparesis/hemiplegia and cranial nerve palsies. This is comparable to the 
results of study by Bousser et al which is 35%.57 Focal neurological deficit 
comprises hemiparesis usually with facial sparing (as “face area” in cerebral 
cortex is drained by sylvian vein which is a tributary of cavernous sinus) and 
lower limb more severely affected than upper limb.  
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5. FEVER:  
 In our study 32.18% of patients had fever either before or at the onset of 
stroke. Infection and fever are one of the important predisposing factors for 
CVT. When deep cerebral veins are affected patients may have high grade fever 
due to involvement of Pons.56 One of the patients in our study had large 
brainstem infarct and persistent hyper pyrexia.    
6. VISUAL DISTURBANCES: 
 Among the 87 patients studied 12.64 % had visual disturbances in the 
form of blurring of vision, diplopia or transient loss of vision.  6 Th cranial nerve 
compression due to raised intra cranial pressure can lead to lateral rectus palsy 
and diplopia.1 Posterior Reversible Encephalopathy Syndrome causes transient 
loss of vision.     
7. BLOOD PRESSURE: 
 We observed that 45% of patients with obstetric CVA suffered from 
Hypertensive disorders. Of them, 31.03% had blood pressure >/= 140/90 and < 
160/110.  Only 13.79 % of the patients had BP >/= 160/110.  James et al have 
reported that only 20% of cases with CVA related to  Pre Eclamptic Toxemia 
exhibit sustained diastolic pressures of > 105 mm Hg before the event of 
stroke.6 
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INVESTIGATIONS 
ANAEMIA: 
 Brig Kumaravelu S et al has observed in 2008 that haematological 
abnormalities especially anemia is an important predisposing factor for 
peripartum CVA.77 In our study 62.06% of patients were anemic. Among them 
24% were severely anemic with haemoglobin level < 7g/dl.  Risk factors like 
pre eclampsia, infection and transfusion are prevalent in patients with low 
haemoglobin levels and this explains the increased  incidence of CVA in 
patients with anemia. 
RADIOLOGICAL FINDINGS: 
 Radiological investigations were carried out for all patients. 54% had 
findings suggestive of CVT. 16% had findings suggestive of  Posterior 
Reversible Encephalopathy Syndrome. Eight patients had typical clinical feature 
of CVT but imaging studies were normal. Sirinivasan K has encountered 50 
cases of severe CVT among 10000 deliveries. It has been estimated that the 
prevalence rate in developing countries is approximately 10 times more than 
that in developed countries. Among those with CVT, 44.68 % had Hemorrhagic 
infarct and 31.91% had Non hemorrhagic infarct. Similar observations were 
noted by Dixit et al 48.4% and 32% respectively3. Empty Delta sign, presented 
in 27% indicates Superior Sagittal Sinus involvement.11 patients had mass 
effect with midline shift which is a sign of bad prognosis. 
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SINUSES INVOLVED: 
 In Magnetic Resonance Venogram hyperintense area was noted in the 
affected sinuses instead of hypointense flow void. MR Angiogram showed 
filling defect due to mass effect caused by hemorrhage/infarct.   In Cerebral 
Venous Thrombosis, we observed that Superior Sagittal Sinus is the most 
common site of involvement.70.21 % patients had SSS involvement followed 
by Transverse sinus with 34.04 %. Similar observations were obtained by Strolz 
E et al with 72.2% and Ameri et al with 72%.  
MANAGEMENT: 
 All the patients with CVA admitted in Intensive Care Unit. Multi 
disciplinary treatment was made involving the Obstetrician, Physician, 
Neurophysician, Radiologist and Physiotherapist. 
 Unfractionated Heparin was given in a dose of 5000 units subcutaneously 
thrice daily for patients with Arterial infarct or CVT. Anti convulsants, anti 
edema measures and anti hypertensives were given in an appropriate manner. 
Coagulation profile was monitored periodically before and during heparin 
therapy. 
 Measures were taken to prevent aspiration, bed sores and infections. The 
risk factors like anemia, dehydration and fever were corrected simultaneously.  
After the acute phase, stable patients were shifted to ward and anti coagulation 
was maintained with Tablet. Warfarin.  
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OUTCOME: 
 69% of patients recovered without neurological deficit within four weeks.  
17.24% of patients had neurological deficits like hemiparesis. Patients with 
CVT/ venous infarct had good outcome in the form of complete recovery.  
Residual defects were noted in patients with haemorrhage and arterial infarcts.  
The mortality rate was 13.79%    
MORTALITY: 
 Total Maternal mortality in Tirunelveli Medical College Hospital  during 
the study period was 87, out of which 12 deaths (13.79%)  have occurred due to 
Cerebral Vascular Accidents. Maximum deaths occurred due to intra cranial 
hemorrhages which accounts for 41.5% of total deaths due to CVA. We 
observed that all 5 patients who died of CVT had haemorrhagic infarct. Daif A 
et al and Treadwell SD et al have mentioned haemorrhagic infarct and empty 
delta sign as poor prognostic indicators.1,76 In the present study we observed that 
higher maternal age, Hypertensive disorders, Haemorrhagic infarct and Intra 
cranial haemorrhage as poor prognostic factors. 
 Bousser MG has reported mortality rate of 5-30% due to obstetric CVA 
which varies according to the time of intervention57. The mortality from all-
cause CVT is 3–10%, though the rate is significantly low for pregnancy related 
CVT. When deaths occur, they usually result from Trans tentorial herniation or 
intracranial haemorrhage. 
 
74 
 
                                             SUMMARY 
 Observations obtained through our study are summarized below.  
¾ Highest incidence of stroke was noted in the 18-25 year age group with 
55.17% . 
¾ Maximum occurrence of CVA was noted in Primi gravida and Primipara 
with 43.67%  
¾ 70% of Cerebral Vascular Accidents occurred in lower socio economic 
group ( Class IV &V ) 
¾ 71.26% of patients belong to rural background 
¾ Incidence of CVA was higher in the postpartum period (80.45%) , 
specifically in the second week of postpartum which was 44.82% 
¾ 55.71% of patients with postpartum CVA had undergone LSCS. 
¾ Anemia, as a risk factor, was noted in 62.06% of patients. Second 
common risk factor was Hypertensive disorders which was present in 
44.82%. 
¾ Most common clinical feature was headache followed by convulsions 
¾ More than half of the patients (56%) had altered sensorium   
¾ Generalized seizures  are more common than Focal seizures 
¾ In the present study most common cause for pregnancy related stroke was 
CVT accounting for 63% 
¾ In CVT,  Superior Sagittal Sinus thrombosis was the most common 
pathology, noted in 72.72%  
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¾ Complete recovery was noted in 68.96% of patients and PRES and 
Venous infarct had good prognosis. The mortality was 13.79%. Patients 
with ICH or Haemorrhagic infarct had high mortality. 
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CONCLUSION 
 
 CVA is one of the serious complications of pregnancy and puerperium 
and it is a recognized cause for maternal mortality. It has a wide spectrum of 
clinical presentation.  
 CVT is the commonest cause for pregnancy related stroke. Though 
hypercoagulable state of pregnancy creates the risk, it is possible to prevent 
CVA by timely identification and correction of risk factors.  Important risk 
factors are anemia, preeclampsia, infection, operative procedures and 
dehydration. 
 Classical symptoms of CVT are headache, convulsions and altered 
sensorium. Investigations should be aimed at identification of not only the 
diagnosis also the etiology like thrombophilias.  The ideal imaging modality for 
CVT is MRI with MR Venography.   
 Patients with arterial or venous infarct are treated with Heparin followed 
by oral anti coagulants. Of all the patients with  pregnancy related CVA, 
patients with CVT have better prognosis except those with haemorrhagic 
infarct. 
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SUGGESTIONS 
 
¾ People should be made aware of the risk factors and early symptoms of 
CVA.  
¾ Risk factors like anemia, pre eclampsia, infection and dehydration should 
be identified at the level of Primary health care systems itself. 
¾  Identification of risk factors and recommendations for thrombo 
prophylaxis should be considered in our day to day practice. 
¾ Patients with higher chance for CVA should be referred to the tertiary 
care center without delay. 
¾ At the onset of symptoms, treatment should be initiated at the earliest. 
¾ Postpartum headache deserves prompt and focused evaluation. 
¾ Specific protocols may be designed to reduce the devastation caused by 
stroke related to pregnancy and puerperium. 
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PROFORMA 
CVA  IN  PREGNANCY  AND  PUERPERIUM 
 
HISTORY : 
Name :                                                                  Age : 
IP No. :                                                                 Address : 
Contact number: 
 Socio economic status : 
Time of presentation :    Antenatal / Postnatal 
If AN, LMP:                     EDD:                         Gestational Age : 
If  PN, Mode of deliver : 
Postnatal day: 
Significant AP/IP/PP History: 
Symptoms: 
Headache - 
Nausea / Vomiting – 
Altered sensorium- 
Fever - 
Convulsions - 
Neurological deficit - 
Visual disturbance- 
 
 
 
Past History :   
HT / PIH / DM / Heart disease / Seizure disorder / TIA / Bleeding 
diathesis / Migraine / Repeated abortions / OCP intake/ Auto immune disorders 
Personal History : 
Smoking / Alcohol and other substance abuse 
EXAMINATION : 
General Examination : 
Pallor / Jaundice / Pedal edema / Cyanosis / Clubbing / Lymphadenopathy 
Evidence of DVT 
Blood pressure - 
Pulse Rate - Temperature - 
Respiratory Rate and Type - 
CVS - 
RS - 
P/A - 
P/V - 
Neurological Examination : 
Level of consciousness - 
Orientation - 
Cranial Nerves - 
Motor System –  
Sensory System - 
 
 
Cerebellar Function - 
Fundus Examination - 
Neck stiffness- 
INVESTIGATIONS: 
Complete blood count 
 BT and CT  
Urinalysis - 
Blood Sugar - 
Blood Urea - 
Serum Creatinine – 
Liver function test- 
Serum Electrolytes - 
Blood group and Type- 
Chest X-ray - 
ECG - 
HIV and VDR L - 
Radiological investigations: CT Brain /MRI/ MR Venogram- 
Other Investigations – 
DIAGNOSIS: 
TREATMENT:                                                
OUTCOME: 
 
S.N
O NAME
AG
E 1P.NO
SOCIOE
CONOM
IC 
STATUS
   
ARE
A
OBS.CO
DE
TIME 
OF 
PRES
ENTA
TION
     GA
MODE OF 
DELIVER
Y
 PP WEEK RISK FACTORS SYMPTOMS     BP CONSCIOUSNESS SEIZURES
TEMP
ERAT
URE
    
FUND
US
Hb 
LEV
EL
RADIOLOG
ICAL 
FINDING
CVT 
FEATURE
SINUS 
INVOLV
ED
OUTCO
ME
1 Mariammal 26 2460       IV       R    P1L0       PP     NA        LN     II   WK PE/AN H/C/AS/NS 140/90 Stuporous     GTCS       AF         P 7          ICH     NA     NA RD
2 sundari 20 3007       IV       R    Primi       AP   34 WK        NA        NA Severe PE H/C/F/V 150/110 Conscious     GTCS        F        N 10        PRES     NA     NA RND
3 Panneerselvi 21 3989       V       R    P1L1       PP     NA
 
Instrument
al
     I   WK AN/BT C/AS/ND 120/80 Drowsy     Focal       AF        N 4.6      Normal     NA     NA RND
4 devi 28 5977       V       U   P3L2       PP     NA        LN     II   WK AN H/AS/F/NS 110/80 Drowsy       NA        F        N 7         NHI/CS TS/SG RND
5 Jayalakshmi 23 6705       V       R     P2L2       PP     NA        LN    III  WK PE/DH C/AS/ND/NS 140/90 Comatose     GTCS       AF        P 9         VI/CVT HI/ME/E SS/TS/ST D
6 mumtaj 30 8907       V       R    P3L3       PP     NA        LN     II   WK AN/ BT H/AS/F 120/80 Drowsy       NA        F        N 3.6         VI/CVT HI/E SS RND
7 mariasudha 21 10232      III       R     P1L1       PP     NA       LSCS     II   WK AN/DH H/VD/AS 100/70 Drowsy       NA       AF        N 6.8         VI/CVT NHI SS RND
8 santhanamari 21 11765      IV       R    G2A1       AP   32 WK        NA        NA PE H/C/AS/V 150/100 Drowsy     GTCS       AF       P 10.2          ICH     NA     NA RD
9 Kanniammal 25 9671       V       U   P2L3       PP     NA         LN      I   WK Twin C/ND 130/80 Conscious     GTCS       AF        N 10.2          VI/CVT NHI/CS/E SS RND
10 Prema 18 10879       V       R     Primi       AP   28 WK        NA        NA Severe PE H/V/VD 150/110 Conscious       NA       AF       AS 11           AI     NA     NA RD
11 Sivakami 22 12430       II       U     P1L1       PP     NA
 
Instrument
al
   IV   WK GHT H/VD/ND 140/100 Conscious       NA       AF        N 10.5        PRES     NA     NA RND
12 Muthumari 35 11005      V       R     P4L4       PP     NA       LSCS     II   WK CHT/AN C/F/AS/V 140/90 Drowsy     GTCS        F        N 7.9        PRES     NA     NA RND
13 Magesh 21 11915     III       U     P2L2       PP     NA        LN    III  WK AN/F AS/F/ND 100/70 Comatose       NA        F        N 8          AI     NA     NA D
14 Shanmugavadivu 41 17446      V       R     P3L2       PP     NA      LSCS     II   WK PE/PPH/STH/ BT H/C/AS/NS 140/90 Stuporous     GTCS       AF        N 11
         
VI/CVT HI/ME/E SS/SG/ST D
15 Ponmalar 24 17993      V       R     P1L1       PP     NA       LSCS      I   WK AN H/C/AS 120/70 Drowsy     GTCS       AF        N 7.9     Normal     NA     NA RND
16 Jasmine 21 18108      IV       R     P1L1       PP     NA         LN    III  WK AN H/ND 110/70 Conscious       NA       AF        N 6.9          AI     NA     NA RD
17 Valli 32 20086       V       R    P3L3       PP     NA         LN     II   WK AN/BT AS/F/NS 110/70 Drowsy       NA        F        N 3.9         VI/CVT NHI TS RND
18 Zareena 19 21254     IV       U    P1L1       PP     NA       LSCS     II   WK PE/AN H/C/AS 140/100 Drowsy     GTCS       AF         P 8.5          ICH     NA     NA RD
19 Subbulakshmi 30 22085      III       R    P2L2       PP     NA       LSCS      I   WK AN H/C/F/V 120/70 Conscious     Focal        F         P 6.5         VI/CVT HI/E SS RND
20 Kavitha 25 22294      V       U     P1L1       PP     NA
 
Instrument
al
   IV   WK GDM H/C/AS 120/80 Drowsy     GTCS       AF        N 13         VI/CVT NHI/ME/E SS RND
22 Mariammal 32 25438      V       R    P3L3       PP     NA         LN    IV   WK AN/DH H/C/F/ND 110/70 Conscious     Focal        F        N 8         VI/CVT ED/E SS/SG RND
23 Arumugakani 38 26077     IV       R    P4L4       PP     NA       LSCS     II   WK AN/BT AS/NS 110/70 Drowsy       NA       AF        N 5         VI/CVT HI TS RND
MASTER CHART
24 Lakshmi 22 29854     III       U     P1L1       PP     NA       LSCS      I   WK DH H/C/ND 120/70 Conscious     Focal       AF        N 12.1      Normal     NA     NA RND
25 Mythili 24 30921     V       R     P1L1       PP     NA       LSCS     II   WK F/DH H/AS/F 100/70 Drowsy       NA        F        N 10.3         VI/CVT ED/E SS/JS RND
26 Parameshwari 28 32756    V       R  G2P1L1       AP    34 WK        NA        NA AN C/AS/F/NS 130/80 Drowsy     GTCS        F        N 7         ICH     NA     NA RD
27 Kavipriya 23 35490    III       R    P2L2       PP     NA
 
Instrument
al
    II   WK PPH/BT/DH H/C/V 110/70 Conscious     GTCS       AF        N 10.7         VI/CVT HI/ME/E SS RND
28 Meena 17 36054      I       U    Primi       AP   24 WK        NA        NA TA ND/NS 120/80 Conscious       NA       AF        N 11      AI     NA     NA RD
29 Muthuselvi 24 39551    IV       R     P1L2       PP     NA       LSCS     II   WK Twin/PE H/C/AS 130/100 Stuporous     GTCS       AF        N 12.2         VI/CVT ED/CS/E SS RND
30 Kannimariyal 34 41257     V       U   P2L2A1       PP     NA       LSCS     II   WK AN/DH AS/ND 110/70 Drowsy       NA       AF        N 8         VI/CVT ED/E SS RND
31 Grace 24 44872     V       R     P1L1       PP     NA       LSCS     II   WK PPH/BT AS/F/V 100/70 Drowsy       NA        F        N 11         VI/CVT NHI TS/ST RND
31 Poomala 25 23448     IV       R   Primi       AP    12 WK        NA        NA SLE Flare/RF ND/F 120/80 Conscious       NA        F        N 10.1      AI     NA     NA D
32 Thavamani 26 48220     IV       R     P1L1       PP     NA       LSCS    III  WK AN H/C/NS 110/80 Conscious     GTCS       AF        N 8.6         VI/CVT HI/ME/E SS RND
33 Mariammal 35 50023     V       R     P3L3       PP     NA         LN     II   WK CHT/AN H/F/V 150/90 Conscious       NA        F      AS 7.4        AI     NA     NA RD
34 Vijayarani 29 51389      I       U G4P1L1A2       AP
   26 
WK        NA        NA SeverePE/F C/AS/F 160/100 Stuporous     GTCS        F       P 11      ICH     NA     NA D
35 Niraimathi 31 52431     IV       R    P3L2       PP     NA       LSCS     II   WK AN/DH H/C 110/70 Conscious     GTCS       AF        N 8         VI/CVT NHI/E TS RND
36 Manjula 18 54882     III       U    P1L1       PP     NA         LN     II   WK AN/GHT H/C/NS 150/90 Conscious     GTCS       AF        N 8.8      Normal     NA     NA RND
37 Esakkiammal 21 55012     V       R    P2L2       PP     NA         LN    IV   WK AN/BT AS/F 110/70 Drowsy       NA        F        N 5.8         VI/CVT HI/CS TS RND
38 Palanimuthu 27 56301     IV       R   P3L3       PP     NA         LN      I   WK PE/AN H/C/V/ND 140/90 Conscious     Focal       AF        P 9      VI/CVT HI/ME/E SS/SG D
39 Muthumari 31 59350     V       R
 
G4P1L1
A2
      AP    35 WK        NA        NA PE/AN H/C/V 150/90 Conscious     GTCS       AF        N 6.6        PRES     NA     NA RND
40 Deepa 20 60328      II       U   P1L2       PP     NA       LSCS     II   WK Twin/PE/DH H/VD/ND 140/110 Conscious       NA       AF        N 10.4        PRES     NA     NA RND
41 Piramachi 25 7036     IV       R   P1L1       PP     NA
 
Instrument
al
    II   WK PE/AN/DH H/C/AS/ND 140/100 Comatose     GTCS       AF        N 8.8      VI/CVT HI/ME/E SS/SG/JS D
42 Sudha 21 9821     V       U    Primi       AP   32  WK         NA        NA SeverePE/AN C/ND/AS 160/100 Drowsy     Focal       AF        N 8        PRES     NA     NA RND
43 Annaselvi 24 13058     III       R     P1L1       PP     NA         LN     II   WK AN/DH H/C/AS/NS 110/80 Drowsy     GTCS       AF        N 7.8         VI/CVT NHI/E TS RD
44 Pandiselvi 28 19236      V       R   P2L2A1       PP     NA       LSCS     II   WK PE H/AS 140/90 Drowsy       NA       AF        N 10.1        PRES     NA     NA RND
45 Rajeshwari 22 20621       II       R    P2L1       PP     NA       LSCS      I   WK AN H/C/ND 110/70 Conscious     GTCS       AF        N 7.4         VI/CVT ED/CS SS RND
46 Ramalakshmi 30 22979     IV       R   P4L3       PP     NA       LSCS     II   WK SeverePE AS/F/V/ND 160/100 Stuporous       NA        F        N 10.7         ICH     NA     NA D
47 Suganthi 33 23011     III       U   P3L3       PP     NA         LN     II   WK AN H/F/V/NS 120/80 Conscious       NA        F        P 7         VI/CVT ED SS/SG RND
48 Lathamary 23 23894     V       R    P2L2       PP     NA       LSCS    III  WK AN/DH H/C/NS 100/70 Conscious     GTCS       AF        N 7.4         VI/CVT NHI/CS SS RD
49 Ushadevi 20 24145    IV       U     P1L1       PP     NA       LSCS      I   WK PE/DH H/C/AS/V 130/100 Drowsy     Focal       AF        N 10.2         VI/CVT HI/E TS RND
50 Juliet 27 25379    III       U   G2P1L1       AP   36 WK        NA        NA PE/AN H/C/AS 140/100 Drowsy     GTCS       AF        N 8.8        PRES     NA     NA RND
51 Anitha 20 25870     V       R     P1L1       PP     NA       LSCS     II   WK AN/ HD/DH ND/VD 120/60 Conscious       NA       AF        N 8.9      Normal     NA     NA RND
52 Thangaselvi 31 26232    IV       R    G2A1       AP   34 WK        NA        NA SeverePE H/C/AS/NS 160/110 Stuporous     GTCS       AF      P 11       ICH     NA     NA RD
53 Mariammal 25 27399     V       R    P1L1       PP     NA
 
Instrument
al
     I   WK AN/DH H/C/AS/ND 120/70 Drowsy     Focal       AF        N 7         VI/CVT NHI/ME/E SS RD
54 Banu 33 27883     III       U    P3L4       PP     NA         LN     II   WK Twin/AN H/C/F/V 130/80 Conscious     GTCS        F        N 8.6         VI/CVT ED/CS SS RND
55 Mallika 23 28001      II       U    P2L0       PP     NA       LSCS      I   WK Severe PE H/C/AS/NS 150/100 Drowsy     GTCS       AF        N 11.2        PRES     NA     NA RND
56 Muneeshwari 21 28562      V       R     P1L1       PP     NA       LSCS     II   WK AN H/C/ND 120/80 Conscious     Focal       AF        N 7.8         VI/CVT HI/CS/E SS/JS RND
57 Chitra 22 28992     IV       R   P2L1       PP     NA        LSCS    III  WK  SeverePE/AN H/V/F 160/100 Conscious       NA       F        N 8         ICH     NA     NA D
58 Poomari 31 29034     III       R   P3L3       PP     NA         LN     II   WK AN/BT AS/ND 110/70 Drowsy       NA       AF        N 2.8         AI     NA     NA RD
59 Devipriya 18 29870     V       R   Primi       AP   37 WK        NA        NA PE/AN H/C/AS/V 140/100 Drowsy     GTCS       AF         P 7.4
        
VI/CVT HI/ED SS RND
60 Krishnammal 22 30104     IV       R   P2L2       PP     NA       LSCS     II   WK AN/BT H/C/F/V 120/80 Conscious     GTCS        F        N 5.8         VI/CVT ED/E SS RND
61 Muppidathi 36 31289     V       R   P4L3       PP     NA       LSCS      I   WK AN H/C/F/NS 120/80 Conscious     GTCS        F        N 8         VI/CVT NHI/E TS RND
62 Chinnakkannu 27 31873     IV       R     P1L1       PP     NA       LSCS     II   WK AN H/C/ND/NS 120/80 Conscious     GTCS       AF        N 8.2      Normal     NA     NA RND
63 Gomathi 23 32010     III       U  G2P1L1       AP   36 WK        NA        NA PE H/C/VD 150/90 Conscious     GTCS       AF        N 12.3        PRES     NA     NA RND
64 Parameshwari 39 32313     V       R   P4L2       PP     NA        LN      I   WK DM/PE/ IUD AS/NS/ND 140/100 Comatose       NA       AF        N 10.1         ICH     NA     NA D
65 Aabithabegum 25 34187       II       U   P1L0       PP     NA       LSCS     II   WK AN/PE/DH H/C/NS 150/100 Conscious     GTCS       AF        N 7         VI/CVT HI TS/JS RND
66 Geetha 27 35087     IV       R   P2L2       PP     NA         LN      I   WK AN/DH H/C/AS 110/70 Drowsy     GTCS       AF        N 7.2         VI/CVT HI/E TS RND
67 Helen 25 37284     V       R     P1L1       PP     NA       LSCS      I   WK AN/DH AS/V 110/70 Drowsy       NA       AF        N 8         VI/CVT NHI/CS SS RND
68 Padma 23 38871    IV       R    G2A1       AP   37 WK        NA        NA PE H/C/F/VD 140/90 Conscious     GTCS        F        N 10.4        PRES     NA     NA RND
69 Tamiselvi 22 40035     III       R    P1L1       PP     NA       LSCS     II   WK AN H/AS/NS 110/80 Drowsy       NA       AF        N 7.4         VI/CVT ED SS RND
70 Eswari 32 41095     V       U    P3L2       PP     NA       LSCS      I   WK PE/DH H/C/AS 140/90 Drowsy     GTCS       AF         P 10.2         VI/CVT HI/ME/E SS/SG RD
71 Maripriya 20 43828    IV       R     P1L1       PP     NA       LSCS     II   WK AN H/C/VD 110/80 Conscious     GTCS       AF        N 8         VI/CVT HI/E TS RND
72 Vijaya 31 45294      II       U    P3L2       PP     NA         LN    III  WK AN/PE H/C 140/100 Conscious     GTCS       AF        N 8.9          AI     NA     NA RD
73 Santhanamari 21 46003     III       R    P2L2       PP     NA         LN     II   WK DH AS/ND 110/70 Drowsy       NA       AF        N 11      Normal     NA     NA RND
74 Kuttiammal 24 49320     V       R   G2P1L1       AP   35 WK        NA        NA AN/PE C/AS/V 140/90 Stuporous     GTCS       AF        N 8.8        PRES     NA     NA RND
75 Kala 30 52924    IV       U   P1L1A2       PP     NA       LSCS      I   WK PE/DH H/AS 140/100 Drowsy       NA       AF        N 10.8         VI/CVT NHI/ME/E SS RND
76 Anandhi 25 56538    III       R    P1L1       PP     NA       LSCS     II   WK PPH/BT C/VD 110/80 Conscious     Focal       AF        N 12         VI/CVT HI SS RND
77 Ramalakshmi 34 57882    V       R    P1L1       PP     NA       LSCS      I   WK CHT H/AS/NS 140/90 Drowsy       NA       AF        P 10.1          ICH     NA     NA D
78 Rejitha 24 58221     V       R    P1L0       PP     NA       LSCS      I   WK AN AS/F/V 120/80 Drowsy       NA        F        N 8.2         VI/CVT ED/CS SS/ST RND
79 Vadivu 20 59023    V       R    G2A1       AP    36 WK        NA        NA PE/AN H/C/VD 160/90 Conscious     GTCS       AF        N 9        PRES     NA     NA RND
80 Dhanalakhmi 29 60048    III       R    P2L2       PP     NA         LN     II   WK Not Found AS/F 120/70 Drowsy       NA        F        N 10.3         VI/CVT HI/E SS RND
81 Kavitha 23 61036     IV       R    P2L2       PP     NA       LSCS      I   WK AN/DH H/AS/F 110/70 Drowsy       NA        F        N 6.8         VI/CVT NHI/ED/E SS RND
82 Sakthi 21 61785     V       U    Primi       AP   28 WK        NA        NA SeverePE C/ND/NS 160/110 Conscious     GTCS       AF        P 11
        
VI/CVT NHI/CS TS RND
83 Jothimani 36 62340     III       R   P3L3       PP     NA         LN     II   WK AN/ HD H/VD 110/70 Conscious       NA       AF        N 8.8         VI/CVT ED SS RND
84 Umarani 25 62941     V       R    P1L1       PP     NA
 
Instrument
al
    II   WK  PE/AN/DH H/C/F/AS 150/110 Stuporous     GTCS        F        P 8.2        VI/CVT HI/ME SS/TS D
85 Vennila 20 64558       II       U    P2L1       PP     NA       LSCS     II   WK AN C/ND/F 110/70 Conscious     Focal        F        N 7.4         VI/CVT HI/E TS/SG RND
86 Sumathi 31 66121      V       R   P3L3       PP     NA         LN      I   WK AN AS/V/ND 120/80 Drowsy       NA       AF        N 7      Normal     NA     NA RND
87 Nagajothi 22 67923     IV       R     P1L1       PP     NA       LSCS     II   WK PE/DH H/AS/F/NS 160/100 Drowsy       NA        F        N 11        PRES     NA     NA RND
 
 
LIST OFABREVIATIONS FOR MASTER CHART 
AI-Arterial infarct 
AF-Afebrile 
AN-Anemia 
AP-Antepartum 
AS-Altered sensorium 
BT-Blood transfusion 
C-Convulsion 
CHT-Chronic hypertension 
CS-Cord sign 
CVT-Cerebral venous thrombosis 
D-Death 
DH-Dehydration 
E-Edema 
Ed-Empty Delta sign 
F-Febrile 
FOCAL-Focal seizures 
GTCS-Generalized Tonic Clonic Seizures 
H-Headache 
HI-Heamorrhagic  infarct 
ICH-Intra cranial haemorrhage 
JS-Jugular sinus 
LN-Labour naturalis 
ME-Mass effect 
N-Normal 
NA-Not applicable 
ND-Neurological deficit 
NS-Neck stiffness 
 
 
P-Papilloedema 
PE- Pre eclampsia 
PP-Postpartum 
PPH-Postpartum haemorrhage 
PRES-Posterior reversible encephalopathy 
R-Rural 
RF-Renal failure 
RND-Recovered, No deficit 
RD-Recovered with deficit 
SG-Sigmoid sinus 
SLE-Systemic lupus erythematosus 
SS-Superior sagittal sinus 
ST-Straight sinus 
TA-Takayasu arteritis 
U-Urban 
V-Vomiting 
VD-Visual defect 
VI-Venous infarct 
